250 related articles for article (PubMed ID: 22997451)
41. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract][Full Text] [Related]
42. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
45. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy for high-risk cervical carcinoma].
Yamamoto R; Sakuragi N; Okamoto K
Nihon Rinsho; 2004 Oct; 62 Suppl 10():169-74. PubMed ID: 15535227
[No Abstract] [Full Text] [Related]
47. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
48. Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
Vitobello D; Siesto G; Pirovano C; Ieda N
Eur J Surg Oncol; 2013 Jan; 39(1):87-93. PubMed ID: 23122543
[TBL] [Abstract][Full Text] [Related]
49. [Detection and diagnosis of early uterine cancer].
Kitao M; Iwanari O
Nihon Rinsho; 1989 May; 47(5):1158-64. PubMed ID: 2746908
[No Abstract] [Full Text] [Related]
50. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
[TBL] [Abstract][Full Text] [Related]
51. Lymph node positivity in cervical cancer.
Heller PB; Lee RB; Leman MH; Park RC
Gynecol Oncol; 1981 Dec; 12(3):328-35. PubMed ID: 7308868
[No Abstract] [Full Text] [Related]
52. Carcinoma of the endometrium with cervical involvement (state II).
Tak WK
Cancer; 1979 Jun; 43(6):2504. PubMed ID: 455235
[No Abstract] [Full Text] [Related]
53. Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.
Ebina Y; Yaegashi N; Katabuchi H; Nagase S; Udagawa Y; Hachisuga T; Saito T; Mikami M; Aoki Y; Yoshikawa H
Int J Clin Oncol; 2015 Apr; 20(2):240-8. PubMed ID: 25800808
[TBL] [Abstract][Full Text] [Related]
54. [Optimal treatment modality for patients with stage-I cervical cancer].
Charkviani LI; Kharaishvili TsN
Vopr Onkol; 1985; 31(3):25-9. PubMed ID: 3992957
[TBL] [Abstract][Full Text] [Related]
55. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy.
Scambia G; Panici PB; Baiocchi G; Amoroso M; Foti E; Greggi S; Mancuso S
Am J Obstet Gynecol; 1991 Feb; 164(2):631-6. PubMed ID: 1992715
[TBL] [Abstract][Full Text] [Related]
56. A population-based survey of the management of women with cancer of the cervix.
Clarke F; Dey P; Collins S
Br J Cancer; 1999 Aug; 80(12):1958-61. PubMed ID: 10471045
[TBL] [Abstract][Full Text] [Related]
57. Esophageal and esophagogastric junction cancers.
Ajani JA; Barthel JS; Bentrem DJ; D'Amico TA; Das P; Denlinger CS; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD;
J Natl Compr Canc Netw; 2011 Aug; 9(8):830-87. PubMed ID: 21900218
[No Abstract] [Full Text] [Related]
58. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer.
Kalaghchi B; Abdi R; Amouzegar-Hashemi F; Esmati E; Alikhasi A
Asian Pac J Cancer Prev; 2016; 17(S3):287-91. PubMed ID: 27165240
[TBL] [Abstract][Full Text] [Related]
59. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
[TBL] [Abstract][Full Text] [Related]
60. [Clinical value of the comprehensive treatment in intermediate and advanced cervical cancer with uterine arterial interventional chemoembolization and radiotherapy].
Tian ZZ; Li S; Liu ML; Zhu XH; Zhao R; Yue YJ; Chen XH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):506-10. PubMed ID: 21029602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
